0
Skip to Content
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Folder: RESOURCES
Back
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels

Monument Therapeutics announces the grant of U.S. patent supporting MT1988 program for schizophrenia

4 Jan
Written by Alexandra Collingbourne
Alexandra Collingbourne
Previous
Previous

Qureight founder: Pitching to investors is energising once you take the plunge

Next
Next

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

LI-In-Bug_small.png

Privacy